TOLMAR THERAPEUTICS, INC. – Trademark Portfolio
Entity Type: 03
TOLMAR THERAPEUTICS, INC. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include ELIGARD. The owner is based in FORT COLLINS, CO.
701 CENTRE AVE.
FORT COLLINS, CO 80526
Showing of trademarks Trademarks
Trademark Classifications
TOLMAR THERAPEUTICS, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does TOLMAR THERAPEUTICS, INC. have?
TOLMAR THERAPEUTICS, INC. has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 cancelled.
What trademark classes does TOLMAR THERAPEUTICS, INC. file in?
TOLMAR THERAPEUTICS, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are TOLMAR THERAPEUTICS, INC.'s most well-known trademarks?
TOLMAR THERAPEUTICS, INC.'s registered trademark portfolio includes well-known marks such as ELIGARD. These are among 2 currently registered trademarks in the portfolio.
What is TOLMAR THERAPEUTICS, INC.'s trademark registration success rate?
TOLMAR THERAPEUTICS, INC. has a 50% trademark registration rate, with 2 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.